ExploreIterate

Renato Skerlj

CEO, President & Board Member

Dr. Skerlj has more than 25 years of experience leading the discovery and development of disease modifying small molecule drugs to treat genetically defined rare diseases. He has authored 67 publications, holds 52 patents and has advanced multiple drug candidates into clinical development.

Most recently, Dr. Skerlj served as Chief Scientific Of...

Social

Roles at Expansion Therapeutics

  • CEO, President & Board Member

    October 5, 2020 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Expansion Therapeutics

My pet peeves

My communication style

Org chart

Manager

No manager

Direct reports

Valerie Cullen

Senior Vice President Research

Mark Ledeboer

Senior Vice President, Drug Discovery

Peter Connolly

Senior Director, Structural Biology

View all

View in org chart
Teams

No teams

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.